GALMED PHARMACEUTICALS LTD. Proceeds from Issuance or Sale of Equity
GALMED PHARMACEUTICALS LTD. (GLMD) reported Proceeds from Issuance or Sale of Equity of $2.70 million for the 1-month period ending 2017-08-31, per its 20-F filed 2018-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2018-03-13
- 2017-08-31: Proceeds from Issuance or Sale of Equity 1 month $2.70M.
| Period end | Proceeds from Issuance or Sale of Equity 1 month |
|---|---|
| 2017-08-31 | $2.70M 20-F · filed 2018-03-13 |